Esomeprazole and naproxen and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Esomeprazole and naproxen and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: esomeprazole / naproxen
Brand name: Vimovo
Synonyms: Naproxen and Esomeprazole
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Esomeprazole and naproxen-Insulin degludec
- Esomeprazole and naproxen-Insulin Degludec (U-100) Prefilled Pens
- Esomeprazole and naproxen-Insulin Degludec (U-100) Vials
- Esomeprazole and naproxen-Insulin Degludec (U-200) Prefilled Pens
- Esomeprazole and naproxen-Insulin degludec and liraglutide
- Esomeprazole and naproxen-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Esomeprazole Capsules
- Insulin aspart, recombinant Subcutaneous-Esomeprazole Delayed-Release Capsules
- Insulin aspart, recombinant Subcutaneous-Esomeprazole Delayed-Release Tablets
- Insulin aspart, recombinant Subcutaneous-Esomeprazole injection
- Insulin aspart, recombinant Subcutaneous-Esomeprazole Magnesium
- Insulin aspart, recombinant Subcutaneous-Esomeprazole Oral, Intravenous